+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Epoprostenol"

Global Pulmonary Arterial Hypertension Market: Analysis By Drug Class, By Type, By Route of Administration, By Distribution Channel, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2028 - Product Thumbnail Image

Global Pulmonary Arterial Hypertension Market: Analysis By Drug Class, By Type, By Route of Administration, By Distribution Channel, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2028

  • Report
  • May 2023
  • 190 Pages
  • Global
From
Pulmonary Hypertension - Pipeline Insight, 2024 - Product Thumbnail Image

Pulmonary Hypertension - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Pulmonary Arterial Hypertension Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Pulmonary Arterial Hypertension Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • January 2024
  • 250 Pages
  • Global
From
Orenitram Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Orenitram Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
India Pulmonary Arterial Hypertension Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

India Pulmonary Arterial Hypertension Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • February 2022
  • 40 Pages
  • India
From
Saudi Arabia Pulmonary Arterial Hypertension Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

Saudi Arabia Pulmonary Arterial Hypertension Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • February 2022
  • 40 Pages
  • Saudi Arabia
From
Epoprostenol Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Epoprostenol Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • October 2023
  • 87 Pages
  • Global
From
Prostacyclin Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Prostacyclin Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • July 2023
  • 93 Pages
  • Global
From
Africa Pulmonary Arterial Hypertension Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

Africa Pulmonary Arterial Hypertension Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • February 2022
  • 80 Pages
  • Africa
From
Brazil Pulmonary Arterial Hypertension Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

Brazil Pulmonary Arterial Hypertension Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • February 2022
  • 40 Pages
  • Brazil
From
China Pulmonary Arterial Hypertension Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

China Pulmonary Arterial Hypertension Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • February 2022
  • 40 Pages
  • China
From
France Pulmonary Arterial Hypertension Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

France Pulmonary Arterial Hypertension Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • February 2022
  • 40 Pages
  • France
From
Germany Pulmonary Arterial Hypertension Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

Germany Pulmonary Arterial Hypertension Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • February 2022
  • 40 Pages
  • Germany
From
Ireland Pulmonary Arterial Hypertension Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

Ireland Pulmonary Arterial Hypertension Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • February 2022
  • 40 Pages
  • Ireland
From
Japan Pulmonary Arterial Hypertension Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

Japan Pulmonary Arterial Hypertension Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • February 2022
  • 40 Pages
  • Japan
From
Russia Pulmonary Arterial Hypertension Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

Russia Pulmonary Arterial Hypertension Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • February 2022
  • 40 Pages
  • Russia
From
South Korea Pulmonary Arterial Hypertension Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

South Korea Pulmonary Arterial Hypertension Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • February 2022
  • 40 Pages
  • South Korea
From
United States Pulmonary Arterial Hypertension Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

United States Pulmonary Arterial Hypertension Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • February 2022
  • 40 Pages
  • United States
From
Vietnam Pulmonary Arterial Hypertension Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

Vietnam Pulmonary Arterial Hypertension Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • February 2022
  • 40 Pages
  • Vietnam
From
  • 19 Results (Page 1 of 1)
Loading Indicator

Epoprostenol is a cardiovascular drug used to treat pulmonary arterial hypertension (PAH). It is a prostacyclin analogue that works by relaxing the blood vessels in the lungs, allowing for improved blood flow and oxygenation. It is administered intravenously or subcutaneously, and is typically used in combination with other drugs to treat PAH. Epoprostenol is also used to treat other conditions such as Raynaud's phenomenon and scleroderma. Epoprostenol is a relatively new drug, having been approved by the US Food and Drug Administration in 1995. It is available in both generic and brand name forms, and is typically prescribed by a cardiologist or pulmonologist. The epoprostenol market is highly competitive, with several major pharmaceutical companies offering the drug. These include GlaxoSmithKline, Pfizer, Novartis, and Bayer. Additionally, there are several generic manufacturers that produce the drug, such as Mylan, Teva, and Sandoz. Show Less Read more